1. Home
  2. CBAN vs RLMD Comparison

CBAN vs RLMD Comparison

Compare CBAN & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

N/A

Current Price

$20.31

Market Cap

423.6M

Sector

Finance

ML Signal

N/A

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.17

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
RLMD
Founded
1975
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
423.6M
461.9M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
CBAN
RLMD
Price
$20.31
$3.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $25.13
$10.75
AVG Volume (30 Days)
114.7K
★ 1.3M
Earning Date
10-21-2026
11-12-2026
Dividend Yield
★ 2.39%
N/A
EPS Growth
16.91
★ 45.28
EPS
★ 0.90
N/A
Revenue
N/A
★ $13,070.00
Revenue This Year
$27.95
N/A
Revenue Next Year
$34.25
N/A
P/E Ratio
$22.31
★ N/A
Revenue Growth
N/A
★ 154.83
52 Week Low
$15.80
$1.80
52 Week High
$22.46
$8.00

Technical Indicators

Market Signals
Indicator
CBAN
RLMD
Relative Strength Index (RSI) 40.80 22.55
Support Level $20.03 N/A
Resistance Level $20.40 $4.44
Average True Range (ATR) 0.46 0.19
MACD -0.03 -0.05
Stochastic Oscillator 43.42 9.83

Price Performance

Historical Comparison
CBAN
RLMD

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: